Kodiak Sciences IncNASDAQ:KOD
- LAST PRICE6.1900
- TODAY'S CHANGE (%)0.2900 (4.9153%)
- Bid / Lots5.6000/ 1
- Ask / Lots6.2800/ 2
- Open / Previous Close5.9000 / 5.9000
- Day Range
- 52 Week Range
- Volume267,467
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | KOD |
|---|---|---|
| 09:32 ET | 2314 | 5.9 |
| 09:35 ET | 1000 | 5.825 |
| 09:37 ET | 100 | 5.885 |
| 09:39 ET | 12149 | 6.04 |
| 09:42 ET | 13713 | 6.08 |
| 09:44 ET | 100 | 6.08 |
| 09:48 ET | 400 | 6.055 |
| 09:50 ET | 2649 | 6.125 |
| 09:51 ET | 3400 | 6.09 |
| 09:53 ET | 265 | 6.1 |
| 09:55 ET | 200 | 6.08 |
| 10:00 ET | 200 | 6.1 |
| 10:02 ET | 200 | 6.08 |
| 10:04 ET | 3000 | 6.14 |
| 10:06 ET | 300 | 6.105 |
| 10:08 ET | 700 | 6.13 |
| 10:09 ET | 700 | 6.16 |
| 10:13 ET | 763 | 6.15 |
| 10:15 ET | 1251 | 6.1363 |
| 10:18 ET | 2760 | 6.2 |
| 10:20 ET | 2691 | 6.25 |
| 10:22 ET | 288 | 6.28 |
| 10:24 ET | 4397 | 6.22 |
| 10:26 ET | 2100 | 6.24 |
| 10:27 ET | 1024 | 6.2095 |
| 10:29 ET | 1800 | 6.175 |
| 10:31 ET | 1748 | 6.15 |
| 10:33 ET | 500 | 6.13 |
| 10:38 ET | 100 | 6.13 |
| 10:42 ET | 100 | 6.13 |
| 10:45 ET | 536 | 6.1 |
| 10:47 ET | 700 | 6.095 |
| 10:49 ET | 100 | 6.095 |
| 10:51 ET | 1232 | 6.065 |
| 10:54 ET | 100 | 6.065 |
| 10:56 ET | 100 | 6.04 |
| 10:58 ET | 100 | 6.04 |
| 11:00 ET | 3768 | 6.095 |
| 11:02 ET | 200 | 6.11 |
| 11:03 ET | 300 | 6.085 |
| 11:09 ET | 539 | 6.135 |
| 11:12 ET | 2200 | 6.1199 |
| 11:14 ET | 100 | 6.12 |
| 11:16 ET | 200 | 6.13 |
| 11:18 ET | 1600 | 6.08 |
| 11:21 ET | 400 | 6.075 |
| 11:23 ET | 100 | 6.07 |
| 11:25 ET | 530 | 6.1 |
| 11:27 ET | 175 | 6.072 |
| 11:34 ET | 2400 | 6.11 |
| 11:36 ET | 2598 | 6.1 |
| 11:39 ET | 320 | 6.085 |
| 11:43 ET | 100 | 6.095 |
| 11:48 ET | 100 | 6.07 |
| 11:50 ET | 2261 | 6.09 |
| 11:52 ET | 100 | 6.085 |
| 11:57 ET | 300 | 6.07 |
| 11:59 ET | 200 | 6.085 |
| 12:01 ET | 900 | 6.095 |
| 12:03 ET | 5507 | 6.115 |
| 12:06 ET | 300 | 6.12 |
| 12:08 ET | 2172 | 6.11 |
| 12:12 ET | 100 | 6.08 |
| 12:17 ET | 100 | 6.105 |
| 12:28 ET | 400 | 6.11 |
| 12:30 ET | 100 | 6.1 |
| 12:32 ET | 900 | 6.1 |
| 12:33 ET | 1291 | 6.08 |
| 12:35 ET | 4197 | 6.119 |
| 12:37 ET | 200 | 6.125 |
| 12:39 ET | 5408 | 6.125 |
| 12:42 ET | 6808 | 6.185 |
| 12:46 ET | 500 | 6.185 |
| 12:48 ET | 1900 | 6.2025 |
| 12:50 ET | 200 | 6.205 |
| 12:51 ET | 242 | 6.21 |
| 12:57 ET | 2100 | 6.235 |
| 01:00 ET | 1247 | 6.23 |
| 01:02 ET | 190 | 6.23 |
| 01:04 ET | 100 | 6.23 |
| 01:06 ET | 1991 | 6.2 |
| 01:08 ET | 316 | 6.2 |
| 01:09 ET | 233 | 6.1846 |
| 01:15 ET | 100 | 6.195 |
| 01:18 ET | 729 | 6.21 |
| 01:20 ET | 300 | 6.21 |
| 01:26 ET | 500 | 6.21 |
| 01:27 ET | 300 | 6.21 |
| 01:29 ET | 600 | 6.21 |
| 01:33 ET | 100 | 6.23 |
| 01:36 ET | 1199 | 6.22 |
| 01:38 ET | 521 | 6.22 |
| 01:40 ET | 600 | 6.24 |
| 01:42 ET | 1100 | 6.23 |
| 01:44 ET | 100 | 6.22 |
| 01:45 ET | 682 | 6.215 |
| 01:47 ET | 1487 | 6.215 |
| 01:51 ET | 516 | 6.22 |
| 01:54 ET | 200 | 6.2 |
| 01:56 ET | 100 | 6.195 |
| 01:58 ET | 948 | 6.21 |
| 02:00 ET | 851 | 6.23 |
| 02:02 ET | 2400 | 6.225 |
| 02:05 ET | 100 | 6.23 |
| 02:09 ET | 200 | 6.23 |
| 02:12 ET | 634 | 6.25 |
| 02:14 ET | 700 | 6.23 |
| 02:16 ET | 3385 | 6.25 |
| 02:21 ET | 100 | 6.26 |
| 02:25 ET | 100 | 6.26 |
| 02:27 ET | 103 | 6.26 |
| 02:34 ET | 100 | 6.28 |
| 02:36 ET | 2800 | 6.26 |
| 02:38 ET | 300 | 6.255 |
| 02:41 ET | 800 | 6.255 |
| 02:43 ET | 1500 | 6.255 |
| 02:45 ET | 340 | 6.255 |
| 02:50 ET | 1624 | 6.2408 |
| 02:54 ET | 100 | 6.24 |
| 02:57 ET | 4080 | 6.225 |
| 02:59 ET | 889 | 6.224 |
| 03:01 ET | 300 | 6.225 |
| 03:03 ET | 300 | 6.205 |
| 03:06 ET | 100 | 6.18 |
| 03:08 ET | 638 | 6.2 |
| 03:14 ET | 2100 | 6.2073 |
| 03:15 ET | 200 | 6.18 |
| 03:17 ET | 1091 | 6.18 |
| 03:21 ET | 300 | 6.19 |
| 03:24 ET | 300 | 6.19 |
| 03:28 ET | 647 | 6.2 |
| 03:30 ET | 2051 | 6.21 |
| 03:32 ET | 595 | 6.21 |
| 03:33 ET | 200 | 6.21 |
| 03:37 ET | 400 | 6.21 |
| 03:39 ET | 1200 | 6.195 |
| 03:42 ET | 200 | 6.16 |
| 03:44 ET | 900 | 6.13 |
| 03:46 ET | 7875 | 6.1575 |
| 03:48 ET | 3000 | 6.155 |
| 03:50 ET | 700 | 6.1775 |
| 03:51 ET | 900 | 6.2 |
| 03:53 ET | 300 | 6.2 |
| 03:55 ET | 500 | 6.185 |
| 03:57 ET | 1700 | 6.19 |
| 04:00 ET | 35184 | 6.19 |
Nov 15, 2024
DJ Kodiak Sciences Is Maintained at Underweight by Barclays, from 10:01AM ET on Friday Nov 15, 2024 by Dow Jones
10:01AM ET on Friday Nov 15, 2024 by Dow JonesDJ Kodiak Sciences Price Target Maintained With a $3.00/Share by HC Wainwright & Co., from 6:31AM ET on Friday Nov 15, 2024 by Dow Jones
6:31AM ET on Friday Nov 15, 2024 by Dow Jones
Nov 14, 2024
*DJ Kodiak Sciences 3Q Loss/Shr 84c >KOD, from 4:01PM ET on Thursday Nov 14, 2024 by Dow Jones
4:01PM ET on Thursday Nov 14, 2024 by Dow JonesKodiak Sciences Announces Recent Business Highlights and Third Quarter 2024 Financial Results, from 4:01PM ET on Thursday Nov 14, 2024 by Dow Jones
4:01PM ET on Thursday Nov 14, 2024 by Dow Jones
Nov 11, 2024
Kodiak Sciences to Participate in Upcoming Investor Conferences, from 6:15AM ET on Monday Nov 11, 2024 by Dow Jones
6:15AM ET on Monday Nov 11, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Kodiak Sciences Inc | 310.4M | -1.7x | --- |
Design Therapeutics Inc | 315.4M | -6.6x | --- |
Compass Pathways PLC | 304.5M | -2.0x | --- |
Nautilus Biotechnology Inc | 298.8M | -4.3x | --- |
Jasper Therapeutics Inc | 327.6M | -4.6x | --- |
Aldeyra Therapeutics Inc | 286.4M | -6.4x | --- |
Company Information
Kodiak Sciences Inc. is a biopharmaceutical company. The Company has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) Platform, for retinal medicines. Its ABC Platform uses molecular engineering to merge the fields of protein-based and chemistry-based therapies. Its lead investigational medicine, tarcocimab, is a novel anti-vascular endothelial growth factor (anti-VEGF) antibody biopolymer conjugate under development for the treatment of high prevalence retinal vascular diseases, including diabetic retinopathy, the cause of blindness in working-age patients in the developed world, and wet age-related macular degeneration, the cause of blindness in elderly patients. Its second investigational medicine, KSI-501, is a bispecific antibody biopolymer conjugate targeting the pro-inflammatory cytokine interleukin-6 (IL-6) and VEGF. It is also developing a third investigational medicine, KSI-101, an unconjugated bispecific protein targeting IL-6 and VEGF.
Contact Information
- Headquarters
- 1200 PAGE MILL RDPALO ALTO, CA, United States 94304
- Phone
- 650-281-0850
- Fax
- 302-636-5454
Executives
- Chairman of the Board, Chief Executive Officer, Co-Founder
- Victor Perlroth
- Chief Financial Officer, Executive Vice President, Secretary
- John Borgeson
- Lead Independent Director
- Robert Profusek
- Independent Director
- Felix Baker
- Independent Director
- Charles Bancroft
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $310.4M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 52.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.29 |
EPS | $-3.65 |
Book Value | $5.06 |
P/E Ratio | -1.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
